The study of two hospitals was a first for researching the microbiology of the built environment in South Africa – a multi-disciplinary approach to understanding how to design healthier buildings.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Viruses
Menampilkan 201 - 220 dari 488 artikel
We don’t fully understand viruses, and we’re still trying to understand life.
Many respiratory viruses cause us to temporarily lose our sense of smell. But SARS-CoV-2 isn’t like those other viruses. Researchers are now exploring how it differs and whether patients recover.
Scanning through billions of chemicals to find a few potential drugs for treating COVID-19 requires computers that harness together thousands of processors.
Drugs and vaccines to fight the coronavirus are already in clinical trials. It is important to understand the difference between each step in this process as efforts to fight COVID-19 continue.
Our expert assessed all the controlled studies so far on hydroxychloroquine. His findings may surprise you.
As restaurants and cafes re-open, here’s what you can do to limit the chance of coronavirus transmission.
Over the first 100 days of the pandemic, countries that quickly implemented strong policies successfully lowered their death rates faster. There were also some surprises in the successes and failures.
Thinking of SARS-CoV-2 as an invisible enemy with an evil personality and humanlike motivations is a natural offshoot of the way people evolved to anthropomorphize so as not to overlook threats.
Research has yet to support the theory that cash can spread the coronavirus.
Bats get a lot of negative press, but they also make positive contributions to the environment and to our lives.
We blame the coronavirus for the thousands of deaths, but it is actually a hyperactive immune reaction that is the cause of death. An immunologist explains.
Should I wear a mask and gloves in the grocery story? Sanitize my food? A food virologist takes on the top questions people are asking as they shop for food amid the coronavirus pandemic.
A CSIRO survey has found many people are confused about common infections, believing antibiotics can treat colds, flu and other viruses. This could fuel a dangerous rise in drug-resistant superbugs.
Some of the worst health performers in recent weeks have been ‘First World’.
Finding drugs that treat the COVID-19 coronavirus may be just as important as developing a vaccine. But it’s much harder to create effective antivirals than antibiotics.
A biomedical researcher and pediatrician who works with Kawasaki disease and COVID-19 explains the similarities and differences in the worrisome cases doctors are starting to see.
Gilead’s drug Remdesivir showed preliminary positive results in clinical trials. But what is this drug and how, exactly, does it work?
Researchers from Oregon Health and Science University found that variations in genes that code for parts of the cellular alarm system might play a role in how well people fight off COVID-19.
Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven’t been tried before.
Kontributor teratas
-
Lecturer in Virology, Queen's University Belfast
-
Professor Emerita of Biology, Indiana University
-
Research Scientist and Principal Investigator at the Vaccine and Infectious Disease Organization, University of Saskatchewan
-
Adjunct Associate Professor, Faculty of Medicine, The University of Queensland
-
Senior Lecturer in Clinical Microbiology, University of Leicester
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Associate Director of Microbiology, University of California, San Diego
-
Regents' Professor & Chair, Medical Laboratory Science, Texas State University
-
Senior Lecturer in Microbiology, University of Sussex
-
Professor of Medicine and Vice President, Research, McMaster University
-
Professor, Discipline of Paediatrics and Child Health, University of Sydney
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Professor of Medicine, University of Virginia
-
Professor of Medicine, University of East Anglia
-
Virologist, The University of Queensland
